Dipyridamole (Pytazen SR) Tab long-acting 150 mg: Discontinuation
Douglas, the supplier, advises that it can no longer supply this product because of difficulty getting the active ingredient.
Affected product
Douglas, the supplier, advises that it can no longer supply this product because of difficulty getting the active ingredient.
Chemical: Dipyridamole
- Presentation: Tab long-acting 150 mg
- Brand: Pytazen SR
- Pharmacode: 750255
- Subsidy: $13.93
- Measure / Qty: per 60
Key dates
May 2024: Douglas advised of the discontinuation
May/June 2025: Supply expected to run out
31 July 2025: All remaining stock of Pytazen SR expires.
What's Pharmac doing
We have previously sought tenders for the ongoing supply of this product. Unfortunately, we have not had any bids for the on-going supply of dipyridamole.
We are reaching out to various suppliers to gauge their interest in supplying a funded version of this product.
We are seeking advice on what alternative treatments might be available to people who take dipyridamole.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)